Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol [Phase 1]
Phase 1 study in healthy subjects evaluating drug availability of four formulations of verinurad and allopurinol.
-
FDA approval · 2023-04-19FDA Approved: SEVELAMER CARBONATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's sevelamer carbonate as an original-application generic for treating hyperphosphatemia in pat…
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels. [Phase 2]
Phase 2 trial evaluating the safety and efficacy of the highest tolerated dose of runcaciguat in adults with chronic kidney disease.
-
CLINICAL_TRIALS research · 2023-03-31Clinical Trial Update: An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants [Phase 2]
A Phase 2 add-on trial (FIGARO-BM) investigated the relationship between blood biomarkers and finerenone in participants from FIGARO-DKD (CK…
-
CLINICAL_TRIALS research · 2023-03-29Clinical Trial Update: Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia [Phase 4]
A Phase 4 trial evaluating tenapanor as core therapy for hyperphosphatemia in chronic kidney disease patients on dialysis has completed with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetics study evaluating verinurad and allopurinol in combination with cyclosporine and rifampicin in healthy volunteers wi…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Assessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease [NA]
A completed clinical trial exploring the feasibility of N-of-1 trials in pediatric patients with hypertension and chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Gabapentin Versus Loratadine in Uremic Pruritus [Phase 4]
A Phase 4 trial comparing gabapentin to loratadine for uremic pruritus has completed.
-
FDA approval · 2023-03-13FDA Approved: CALCIUM ACETATE — Original Application (SQUARE PHARMACEUTICALS LIMITED)
The FDA approved Square Pharmaceuticals Limited's original application for calcium acetate, making a generic version of this phosphate binde…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis [Phase 3]
Phase 3 trial update for Pegol-Sihematide in anemia associated with chronic kidney disease on dialysis.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia [Phase 2]
Phase 2 trial updating verinurad and allopurinol in chronic kidney disease with hyperuricemia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients [Phase 4]
A Phase 4 clinical trial is evaluating pharmacokinetics of microdose midazolam and several statins in healthy volunteers and patients with c…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Vitamin D, Oxidative Stress and Inflammation in Hemodialysis [Phase 2, Phase 3]
A clinical trial update on the effects of vitamin D on oxidative stress and inflammation in patients undergoing hemodialysis, with phase 2 a…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children [Phase 4]
A phase 4 comparative trial in children with chronic kidney disease comparing oral liposomal iron, iron-supported lactoferrin, and IV iron d…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Effect of Melatonin in Pediatric Hemodialysis Patients [Phase 3]
A Phase 3 trial evaluating the effect of melatonin in pediatric patients undergoing hemodialysis, focusing on complications, oxidative stres…
-
FDA approval · 2023-01-30FDA Approved: TECHNETIUM TC 99M MERTIATIDE — Original Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
The FDA approved Technetium Tc-99m mertiatide (NDA216820) for renal imaging in an original application from Jubilant Radiopharma, enabling a…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Exercise Trial in Chronic Kidney Disease [NA]
A completed clinical trial evaluating exercise intervention in patients with chronic kidney disease; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia [Phase 4]
Phase 4 trial update evaluating the safety and efficacy of Roxadustat for heart failure with chronic kidney disease and anemia.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease [Phase 2]
Phase 2 trial assessing nicotinamide riboside with Co-enzyme Q10 in chronic kidney disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Renal Osteodystrophy: An Individual Management Approach [NA]
A completed clinical trial update discussing an individual management approach to renal osteodystrophy in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Chronic Kidney Disease (CKD) Platelet Study [Phase 3]
Phase 3 clinical trial update for a CKD-related platelet study; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Sodium Lowering and Urinary Protein Reduction Trial [Phase 3]
Phase 3 trial completed evaluating sodium lowering for reducing urinary protein in chronic kidney disease with albuminuria.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease [Phase 2]
Phase 2 trial assessing vascular effects of mineralocorticoid receptor antagonism in chronic kidney disease with albuminuria.
-
FDA approval · 2022-12-16FDA Approved: FUROSEMIDE — Original Application (Lifestar Pharma LLC)
FDA approved Lifestar Pharma LLC's original application for furosemide, authorizing the generic version of the diuretic for its labeled indi…
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency [Phase 4]
Phase 4 trial update evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of CTAP101, immediate-release calcifediol, high-dose…